Legal Representation
Attorney
Katie Miller
USPTO Deadlines
Next Deadline
133 days remaining
NOA E-Mailed - SOU Required
Due Date
June 02, 2026
Extension Available
Until December 02, 2026
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 2, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 7, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 7, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 1, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 6, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 5, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 5, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 5, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 17, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 4, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 4, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 16, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 16, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 16, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 8, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 26, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 13, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and preclinical drug development in the field of cell reprogramming, gene editing technology, specimen procurement, stem cell banking, cell differentiation, cell separation, stem cell generation, gene editing, 2D or 3D model generation, 2D or 3D model drug screening, cell characterization, assay-ready and cryopreserved cell products
Classification
International Classes
042